DNA Analysis Leads to Customized Cancer Medications

Genomic medicine, also known as personalized medicine, analyzes gene sequences in a person’s DNA and uses that information to customize medical care to his or her unique genetic makeup. Because most cancers are associated with damaged or mutated DNA, examining tumor cells at a molecular level can help scientists develop targeted medicines designed to specifically target cancer cells.

Currently, genomic medicine has more implications for the treatment of lung cancer than any other cancer, with breast cancer a close second. In the future, however, it may hold the key to more precise predictions of prognosis, optimal treatment, survival and quality of life for people with a wide variety of cancers.

Multidisciplinary Genomics Tumor Board for Breast Cancer Patients

This team of experts, which includes clinicians, molecular biologists and geneticists, provides personalized recommendations for breast cancer patients based on tumor genome sequencing. The molecular abnormalities discovered by the sequencing of breast cancers provide important targets that may respond to specific drug therapies. The tumor board provides recommendations to patients and their providers regarding what specific treatments and clinical trials may be best for that patient.